Indapamide and Injection site nodule - a phase IV clinical study of FDA data

Summary:

Injection site nodule is reported as a side effect among people who take Indapamide (indapamide), especially for people who are female, 60+ old, also take Bydureon, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Injection site nodule when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Injection site nodule?

Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site) is found to be associated with 414 drugs and 588 conditions by eHealthMe. Check the latest studies of Injection site nodule.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 12 people (0.06%) have Injection site nodule.

Could Indapamide cause Injection site nodule?

Among these 12 people:

What is the gender of people who have Injection site nodule when taking Indapamide? *

female: 75 %
male: 25 %

What is the age of people who have Injection site nodule when taking Indapamide? *

What are other drugs people take besides Indapamide? *

What are other side effects people have besides Injection site nodule? *

Injection Site Bruising: 6 people, 50.00%
Weight Decreased: 6 people, 50.00%
Injection Site Erythema (redness at injection site): 4 people, 33.33%
Blood Glucose Decreased: 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Injection Site Haemorrhage (bleeding from injection site): 3 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 25.00%
Injection Site Pain: 3 people, 25.00%
Gait Disturbance: 3 people, 25.00%
Injury: 2 people, 16.67%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 41.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 25.00%
Sleep Disorder: 2 people, 16.67%
Hot Flush (sudden feelings of heat): 1 person, 8.33%
Breast Cancer: 1 person, 8.33%
Depression: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Dyslipidaemia (abnormal amount of lipids): 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Injection site nodule?

- Check whether Injection site nodule is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,152 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site nodule:

Injection site nodule (414 drugs)

Browse all the conditions that are associated with Injection site nodule:

Injection site nodule (588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.